Leslie Klaff
Endocrinology, Diabetes & Metabolism · Renton, WANPI 1720009764
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,637 of the $2,331 with a category attached, or 70.3%.
Across 31 payments — averaging $75.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Eli Lilly$992
Across 864 payments — averaging $3763.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2.2M
- Ascensia Diabetes Care US Inc.$434K
- Roche Diabetes Care, Inc.$200K
- Pfizer$176K
- Novo Nordisk AS$156K
- Abbott$77K
- plus $25K from 4 others
What the payments were for
- Travel & lodging$1,63770%
- Food & beverage$69330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,331 in reported general payments places this provider in the 65th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.
See all endocrinology, diabetes & metabolism providers in Washington →
Other endocrinology, diabetes & metabolism in Renton
- Ronald BrazgRenton$29K
- Michael ShannonLacey$698K
- Lynn KohlmeierSpokane$518K
- Carol WyshamSpokane$512K
- Bruce WilsonRichland$352K
- Irl HirschSeattle$192K
- Biju KunhiramanYakima$118K
- Nicole EhrhardtSeattle$111K
- Kristina UtzschneiderSeattle$72K
- Savitha SubramanianSeattle$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.